Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome | Zendy

Sérgio Reis Soares | Zendy; Raúl Gómez | Zendy; Carlos Simón | Zendy; Juan A. García-Velasco | Zendy; António Pellicer | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome

Author(s) -

Sérgio Reis Soares,

Raúl Gómez,

Carlos Simón,

Juan A. García-Velasco,

António Pellicer

Publication year - 2008

Publication title -

human reproduction update

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.977

H-Index - 180

eISSN - 1362-4946

pISSN - 1355-4786

DOI - 10.1093/humupd/dmn008

Subject(s) - ovarian hyperstimulation syndrome , vascular endothelial growth factor , endocrinology , medicine , agonist , vascular endothelial growth factor a , dopamine agonist , biology , receptor , in vitro fertilisation , embryo , microbiology and biotechnology , vegf receptors

Ovarian hyperstimulation syndrome (OHSS) typically occurs when ovaries are primed with FSH/LH and subsequently exposed to hCG. The ultimate pathophysiological step underlying this clinical picture is increased vascular permeability (VP).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research